bpc-157 risks human studies TLDR: has not been proven to cause cancer. But it has also not been proven safe in people with active cancer, recent cancer, premalignant conditions, suspicious lesions, or high recurrence risk Programs:8 Week Injury Recovery Protocol (2 vials + consultation) bpc-157 testosterone Home Page NNMT inhibitor

bpc-157 risks human studies TLDR: has not been proven to cause cancer. But it has also not been proven safe in people with active cancer, recent cancer, premalignant conditions, suspicious lesions, or high recurrence risk Programs:8 Week Injury Recovery Protocol (2 vials + consultation) bpc-157 testosterone Home Page NNMT inhibitor

bpc-157 testosterone Home Page does bpc 157 and tb500 –

Tirzepatide is a dual GIP and GLP-1 receptor agonist, targeting two incretin pathways simultaneously

NNMT inhibitor

Programs:8 Week Injury Recovery Protocol (2 vials + consultation)

Zepbound and Mounjaro brief dosing guides Tirzepatide is available in the United States under two brand names, both manufactured by Eli Lilly: Mounjaro – FDA-approved to improve blood sugar control in adults with type 2 diabetes, used alongside diet and exercise Zepbound – FDA-approved for chronic weight management in adults with obesity, or adults who are overweight with at least one weight-related condition